z-logo
open-access-imgOpen Access
Atezolizumab for first-line treatment of metastatic nonsquamous non-small cell lung cancer: what makes the difference?
Author(s) -
Melissa Bersanelli,
Fausto Petrelli
Publication year - 2018
Publication title -
journal of thoracic disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.682
H-Index - 60
eISSN - 2077-6624
pISSN - 2072-1439
DOI - 10.21037/jtd.2018.08.82
Subject(s) - atezolizumab , medicine , lung cancer , oncology , lung , cancer research , immunotherapy , cancer , nivolumab

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here